共 42 条
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
被引:1908
作者:
Sharma, Sreenath V.
[1
]
Lee, Diana Y.
[1
]
Li, Bihua
[1
]
Quinlan, Margaret P.
[1
]
Takahashi, Fumiyuki
[1
]
Maheswaran, Shyamala
[1
]
McDermott, Ultan
[1
]
Azizian, Nancy
[1
]
Zou, Lee
[1
]
Fischbach, Michael A.
[1
]
Wong, Kwok-Kin
[2
]
Brandstetter, Kathleyn
[2
]
Wittner, Ben
[1
]
Ramaswamy, Sridhar
[1
]
Classon, Marie
[1
]
Settleman, Jeff
[1
]
机构:
[1] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
来源:
关键词:
STEM-CELLS;
THERAPEUTIC RESISTANCE;
HISTONE MODIFICATION;
GROWTH;
INSULIN;
MECHANISMS;
SENSITIVITY;
RETREATMENT;
INHIBITORS;
DISEASE;
D O I:
10.1016/j.cell.2010.02.027
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
Accumulating evidence implicates heterogeneity within cancer cell populations in the response to stressful exposures, including drug treatments. While modeling the acute response to various anticancer agents in drug-sensitive human tumor cell lines, we consistently detected a small subpopulation of reversibly "drug-tolerant" cells. These cells demonstrate >100-fold reduced drug sensitivity and maintain viability via engagement of IGF-1 receptor signaling and an altered chromatin state that requires the histone demethylase RBP2/KDM5A/Jarid1A. This drug-tolerant phenotype is transiently acquired and relinquished at low frequency by individual cells within the population, implicating the dynamic regulation of phenotypic heterogeneity in drug tolerance. The drug-tolerant subpopulation can be selectively ablated by treatment with IGF-1 receptor inhibitors or chromatin-modifying agents, potentially yielding a therapeutic opportunity. Together, these findings suggest that cancer cell populations employ a dynamic survival strategy in which individual cells transiently assume a reversibly drug-tolerant state to protect the population from eradication by potentially lethal exposures.
引用
收藏
页码:69 / 80
页数:12
相关论文